CALC 8-K 2026-11-10
CalciMedica, Inc. (CALC) 8-K dated 2026-11-10 — accession 0001193125-26-454430.
CalciMedica, Inc. (CALC) is a biotechnology company listed on US.
CALC: CalciMedica Reports Third Quarter 2026 Financial Results and Provides C…
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Income-statement cache for CALC is thin on this filing URL. We will not invent exhibit numbers.
Not investment advice. The CALC SEC hub lists recent forms. The stock page is the research view.
- Guidance
- expects its cash, cash equivalents and short-term investments to fund its current operating plan into the second half of 2027.
Why it matters
- expects its cash, cash equivalents and short-term investments to fund its current operating plan into the second half of 2027.